Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Fennec Pharmaceuticals Inc. - Common Stock (NQ:FENC)

8.705 -0.265 (-2.95%)
Streaming Delayed Price Updated: 2:02 PM EST, Feb 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Fennec Pharmaceuticals Inc. - Common Stock

< Previous 1 2 Next >
News headline image
Fennec Q2 Sales Jump 33 Percent ↗
Via The Motley Fool
News headline image
Fennec (FENC) Q2 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings Intellectual Property
News headline image
Fennec Pharmaceuticals Inc (NASDAQ:FENC) Reports Mixed Q2 2025 Earnings with Revenue Slight Miss and Wider-Than-Expected Loss ↗
Fennec Pharmaceuticals reported mixed Q2 2025 results, missing revenue estimates by 0.6% and posting a wider EPS loss. PEDMARK® growth and new accounts drove optimism despite financial... 
Via Chartmill
News headline image
Earnings Scheduled For August 14, 2025 ↗
 
Via Benzinga
News headline image
Fennec Pharmaceuticals Earnings Preview ↗
 
Via Benzinga
News headline image
Nasdaq, S&P 500 Hit 6-Month Lows As Recession Fears Grow: What's Driving Markets Monday? ↗
Stocks extended last week's losses on Monday as concerns over the U.S. economy continue to weigh on the market. The Nasdaq 100 saw the steepest declines, with Tesla, Inc. (NASDAQ:TSLA) and Palantir... 
Via Benzinga
Topics Economy Stocks
News headline image
Fennec Pharmaceuticals's Earnings Outlook ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 13, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For March 10, 2025 ↗
 
Via Benzinga
News headline image
Why BP Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
FENC Stock Earnings: Fennec Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024 ↗
FENC stock results show that Fennec Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Earnings Scheduled For November 6, 2023 ↗
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million. 
Via Benzinga
News headline image
Preview: Fennec Pharmaceuticals's Earnings ↗
 
Via Benzinga
News headline image
Analyst Ratings for Fennec Pharmaceuticals ↗
 
Via Benzinga
News headline image
Recap: Fennec Pharmaceuticals Q1 Earnings ↗
 
Via Benzinga
News headline image
3 Dirt-Cheap Stocks Under $10 That Could EXPLODE! ↗
These dirt cheap stocks under $10 have the potential to rise rapidly and create fortunes for bold investors. 
Via InvestorPlace
News headline image
Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
 
Via Benzinga
News headline image
FENC Stock Earnings: Fennec Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024 ↗
FENC stock results show that Fennec Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Earnings Outlook For Fennec Pharmaceuticals ↗
 
Via Benzinga
News headline image
Analyst Ratings for Fennec Pharmaceuticals ↗
 
Via Benzinga
News headline image
Expert Ratings for Fennec Pharmaceuticals ↗
 
Via Benzinga
What 4 Analyst Ratings Have To Say About Fennec Pharmaceuticals ↗
 
Via Benzinga
News headline image
FENC Stock Earnings: Fennec Pharmaceuticals Misses EPS, Beats Revenue for Q4 2023 ↗
FENC stock results show that Fennec Pharmaceuticals missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Earnings Scheduled For March 21, 2024 ↗
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million. 
Via Benzinga
News headline image
4 Analysts Have This to Say About Fennec Pharmaceuticals ↗
 
Via Benzinga
Where Fennec Pharmaceuticals Stands With Analysts ↗
 
Via Benzinga
News headline image
After Two FDA Rejections, Fennec Pharma Lead Drug Scores US Approval For Chemo-Induced Hearing Loss ↗
 
Via Benzinga
News headline image
7 Biotech Stocks Sitting in the Sweet Spot ↗
Biotech stocks have the potential for massive profits if their companies are successful in developing drugs that are safe and marketable. 
Via InvestorPlace
News headline image
US Stocks Open Lower; Dow Dips 250 Points ↗
U.S. stocks traded lower this morning, with the Dow Jones dropping around 250 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.74% to 33,484.47 while the NASDAQ fell... 
Via Benzinga
News headline image
Why Stabilis Solutions Shares Jumped Over 71%; Here Are 70 Biggest Movers From Yesterday ↗
Gainers 
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.